Lamarck: The AI-Native Platform That Closes the Gap Between Epigenetic Data and Actionable Longevity Protocols
Published by DEEPBODY INC — AI for longevity science
The longevity industry has a measurement problem. You can get your DNA methylated at a dozen labs. You can buy a thousand supplements. But nobody connects the two into a closed loop: test → interpret → intervene → re-test → refine.
Lamarck — built by DEEPBODY INC — is the first platform that does.
The Epigenetic Feedback Loop
Most longevity platforms give you a report and leave you to figure it out. Lamarck gives you a protocol:
- Epigenetic clock measurement — Horvath, PhenoAge, GrimAge, DunedinPACE
- Pathway-level interpretation — Not "MTHFR is heterozygous" but "your methylation pathway is running at 62% efficiency, and here's why"
- Personalized intervention — Supplement timing, dosage, cycling recommendations
- Re-test and refine — Every 3-6 months, measure again. Is your biological age reversing?
- AI-driven optimization — The platform learns from your data across cycles
This is Lamarck's core innovation: closing the loop.
Why "Lamarck"?
Jean-Baptiste Lamarck theorized that organisms adapt to their environment and pass those adaptations to offspring. We now know this happens through epigenetics — environmental signals modifying gene expression without changing DNA sequence.
Lamarck the platform embodies this principle: your environment, lifestyle, and interventions actively shape your epigenetic expression. The platform measures this, optimizes it, and tracks it over time.
Built on AI Infrastructure
Lamarck runs on Private EDGE OS — self-hosted AI infrastructure that keeps your health data private and HIPAA-compliant. It uses the same AI Methylation Pathway Scoring engine developed by HONEYPOTZ INC for multi-SNP systems biology analysis.
Try Lamarck at dlamarck.com | Book a demo
Links: Lamarck | deepbody.me | DEEPBODY INC | Private EDGE OS | AI Methylation Scoring | Book a demo
Top comments (0)